Showing results (1841-1850 of 2,670) with videos related to

Sort By:
Pageof 267
Msphere|August 16, 2022
Antibiotics Drive Expansion of Rare Pathogens in a Chronic Infection Microbiome ModelJohn J Varga, Conan Y Zhao, Jacob D Davis, et al.
Pediatric Pulmonology|August 6, 2022
Building a pediatric rare lung disease program: It takes a community of villagesTimothy J Vece, William A Gower, Stephanie D Davis, et al.
Plos One|May 20, 2016
Overwintering of Rabies Virus in Silver Haired Bats (Lasionycteris noctivagans)April D Davis, Shannon M D Morgan, Michelle Dupuis, et al.
Anticancer Research|January 30, 2003
p63 expression profile in normal and malignant prostate epithelial cellsLeland D Davis, Wei Zhang, Axel Merseburger, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 27, 2020
Population Pharmacodynamic Model of Neutrophil Margination and Tolerance to Describe Effect of Sarilumab on Absolute Neutrophil Count in Patients with Rheumatoid ArthritisPavel Kovalenko, Anne Paccaly, Anita Boyapati, et al.
Pilot and Feasibility Studies|August 11, 2022
Comparing an optimised physiotherapy treatment package with usual physiotherapy care for people with tennis elbow - protocol for the OPTimisE pilot and feasibility randomised controlled trialM Bateman, B Saunders, C Littlewood, et al.
Vaccine|November 19, 1997
A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogenD Davis, B Morein, L Akerblom, et al.
Pediatric Pulmonology|February 7, 2018
In children, the microbiota of the nasopharynx and bronchoalveolar lavage fluid are both similar and differentKirsten M Kloepfer, Ashley R Deschamp, Sydney E Ross, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cellsCraig Gedye, Juliet Quirk, Judy Browning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Predicting clinical outcome through molecular profiling in stage III melanomaThomas John, Michael A Black, Tumi T Toro, et al.
Pageof 267